These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 23388161)
1. Role of antiviral therapy in the management of hepatocellular carcinoma. Guan YS; He Q Anticancer Drugs; 2013 Apr; 24(4):337-43. PubMed ID: 23388161 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and C virus-related carcinogenesis. Fung J; Lai CL; Yuen MF Clin Microbiol Infect; 2009 Nov; 15(11):964-70. PubMed ID: 19874379 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic viruses and hepatocellular carcinoma. Ben Ari Z; Weitzman E; Safran M Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Kuzuya T; Katano Y; Kumada T; Toyoda H; Nakano I; Hirooka Y; Itoh A; Ishigami M; Hayashi K; Honda T; Goto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1929-35. PubMed ID: 17914972 [TBL] [Abstract][Full Text] [Related]
6. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044 [TBL] [Abstract][Full Text] [Related]
7. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [TBL] [Abstract][Full Text] [Related]
8. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma. Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455 [TBL] [Abstract][Full Text] [Related]
9. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma. Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517 [TBL] [Abstract][Full Text] [Related]
10. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy. Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396 [TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma. Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247 [TBL] [Abstract][Full Text] [Related]
13. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis]. Schott E; Bergk A; Berg T Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819 [TBL] [Abstract][Full Text] [Related]
14. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma]. Pár A Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671 [TBL] [Abstract][Full Text] [Related]
15. Does anti-HBV therapy benefit the prognosis of HBV-related hepatocellular carcinoma following hepatectomy? Yu LH; Li N; Shi J; Guo WX; Wu MC; Cheng SQ Ann Surg Oncol; 2014 Mar; 21(3):1010-5. PubMed ID: 24121884 [TBL] [Abstract][Full Text] [Related]
16. Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Chan AC; Chok KS; Yuen WK; Chan SC; Poon RT; Lo CM; Fan ST Arch Surg; 2011 Jun; 146(6):675-81. PubMed ID: 21690443 [TBL] [Abstract][Full Text] [Related]
17. Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma. Liaw YF Semin Liver Dis; 2005; 25 Suppl 1():40-7. PubMed ID: 16103980 [TBL] [Abstract][Full Text] [Related]
18. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. Ringelhan M; O'Connor T; Protzer U; Heikenwalder M J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558 [TBL] [Abstract][Full Text] [Related]
19. Current status of hepatitis C virus infection in Korea. Suh DJ; Jeong SH Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792 [TBL] [Abstract][Full Text] [Related]
20. [Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma]. Lengyel G; Fehér J Orv Hetil; 2010 Jul; 151(29):1177-81. PubMed ID: 20591786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]